Drugs / N-Acetylglucosamine
N-Acetylglucosamine
also known as
GlcNAc · 2- acetylamino)-2- deoxy-D-glucose · Bio-nag · GInNAC · Greennag · Marine sweet · NSC-400525 · NSC-524344
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02511041 | Jun 2015 → Jan 2017 | — | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT07225998 | Jun 2026 → Jul 2028 expected | Crohn disease | Johns Hopkins University | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT03716115 | May 2020 → Apr 2021 | protein-energy malnutrition | Queen Mary University of London | Completed | No outcome recorded |
Evidence & citations 12 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | N-Acetylglucosamine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07225998 ↗ |
| Known as | 2- acetylamino)-2- deoxy-D-glucose | “N-acetylglucosamine (GlcNAc), 2-acetamino-2-deoxy- \<=-Dglucose, or 2- acetylamino)-2- deoxy-D-glucose, is a monosaccharide derivative of glucose.” NCT02511041 ↗ |
| Known as | Bio-nag | ChEMBL registry synonym — accepted as the source's own label CHEMBL447878 ↗ |
| Known as | GInNAC | “N-Acetyl Glucosamine (GInNAC)” NCT03716115 ↗ |
| Known as | GlcNAc | “N-acetyl glucosamine (GlcNAc) will be given orally or via NG tube for 14 days, gradually increased from a starting dose of 0.5g, to 1g three times daily to avoid osmotic diarrhoea.” NCT03716115 ↗2“N-acetylglucosamine (GlcNAc), 2-acetamino-2-deoxy- \<=-Dglucose, or 2- acetylamino)-2- deoxy-D-glucose, is a monosaccharide derivative of glucose.” NCT02511041 ↗ “N-Acetylglucosamine (GlcNAc)” NCT07225998 ↗ |
| Known as | Greennag | ChEMBL registry synonym — accepted as the source's own label CHEMBL447878 ↗ |
| Known as | Marine sweet | ChEMBL registry synonym — accepted as the source's own label CHEMBL447878 ↗ |
| Known as | NSC-400525 | ChEMBL registry synonym — accepted as the source's own label CHEMBL447878 ↗ |
| Known as | NSC-524344 | ChEMBL registry synonym — accepted as the source's own label CHEMBL447878 ↗ |
| Action | Restore | “GlcNAc administration has been demonstrated to restore the intestinal epithelial charged barrier in Crohn's disease.” NCT03716115 ↗ |
| Modality | Small molecule | “is a monosaccharide derivative of glucose.” NCT02511041 ↗ |
| Route | Oral | “Patients will self-administer oral GlcNAc” NCT02511041 ↗ |